MIMasanobu Ishii

Masanobu Ishii

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masanobu Ishii has a total of 336 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A First-Visit Clinical Score to Distinguish Immunoglobulin Light-Chain from Wild-Type Transthyretin Cardiac Amyloidosis: Derivation and Internal Validation

    by Yosuke Matsumoto, Yasuhiro Izumiya, Yawara Kawano, Naoto Kuyama, Kei Morikawa, Akihisa Tabira, Masahiro Yamamoto, Kyoko Hirakawa, Masanobu Ishii, Shinsuke Hanatani, et al.

    Background: Delayed diagnosis of immunoglobulin light-chain cardiac amyloidosis (AL-CA) worsens prognosis, partly because AL-CA and wild-type transthyretin cardiac amyloidosis (ATTRwt-CA) are difficult to distinguish at the initial cardiology visit. We developed and validated a practical score to triage AL-CA from ATTRwt-CA. Methods: We retrospectively analyzed 541 consecutive patients with cardiac amyloidosis (91 AL-CA, 450 ATTRwt-CA) at our institution's amyloidosis center, randomly divided into derivation (n=378) and validation (n=163) cohorts. Candidate first-visit variables underwent LASSO selection after multiple imputation, with estimates pooled by Rubin's rules. Performance was assessed by bootstrap validation, calibration, and decision curve analysis. The model was converted into a simplified point-based score. Results: Seven variables were retained: age, absence of atrial fibrillation, absence of carpal tunnel syndrome, low serum albumin, proteinuria (≥1+), low voltage, and thinner left ventricular posterior wall thickness. Areas under the curve (AUC) were 0.97 in the derivation cohort and 0.99 in the validation cohort; the bootstrap optimism-corrected AUC was 0.96. The model provided net benefit across threshold probabilities of 0.01-0.50. Risk tiering categorized the validation cohort into low (0-5 points; AL-CA 0%), intermediate (6?9 points; 26%), and high (10-13 points; 95%) probability groups. Discrimination remained high for AL-CA versus monoclonal protein-positive ATTRwt-CA at a cutoff of ≥8 points (AUC 0.90). Adding this score to monoclonal protein testing significantly improved diagnostic performance compared with monoclonal protein testing alone. Conclusions: This simple first-visit score may help cardiologists rapidly triage suspected AL-CA and prioritize urgent hematology referral and subtype-specific confirmatory testing.

  • Open Access

    Right Atrial Function as a Novel Predictor for New‐Onset Atrial Fibrillation in Transthyretin Amyloid Cardiomyopathy

    by Naoto Kuyama, Yasuhiro Izumiya, Seiji Takashio, Hiroki Usuku, Akihisa Tabira, Hidekazu Kondo, Shotaro Saito, Keisuke Yonezu, Nozomi Kodama, Takuto Zaizen, et al.

    Background: Left atrial functional parameters are established predictors of atrial fibrillation (AF), but the role of right atrial (RA) function, particularly RA peak longitudinal strain (LS), in transthyretin amyloid cardiomyopathy (ATTR‐CM) remains unclear. This study aimed to investigate the relationship between RA function and AF onset in ATTR‐CM. Methods: The derivation cohort comprised 143 patients with ATTR‐CM without prior atrial arrhythmias at Kumamoto University Hospital. Association between baseline parameters and new‐onset AF during the follow‐up period was analyzed using Cox regression models. Discrimination was assessed using time‐dependent receiver operating characteristic analysis at 24 months. Results: During follow‐up (median, 30 months), 42 patients (29%) developed new‐onset AF. Lower RA peak LS was independently associated with incident AF and showed moderate discrimination (time‐dependent area under the curve, 0.72); the optimal cutoff at 24 months was 17.2%. Patients with RA peak LS <17.2% had significantly lower AF‐free survival. A novel risk score integrating RA and left atrial peak LS and LA volume index effectively stratified AF risk. External validation in an independent cohort of 81 patients from Oita and Miyazaki University Hospitals confirmed consistent associations between lower RA peak LS and higher AF incidence, supporting the reproducibility of the findings. Conclusions: RA peak LS is a novel, robust predictor of new‐onset AF in ATTR‐CM and provides additional information alongside established clinical and left atrial parameters. Incorporating RA functional assessment may improve risk stratification and guide early interventions in high‐risk patients.


  • Open Access

    Air pollution before and during the COVID-19 pandemic: changes in risk of acute myocardial infarction

    by Masanobu Ishii, Taishi Nakamura, So Ikebe, Yasuhiro Otsuka, Kenichi Tsujita

    Background and Aims: Ambient PM2.5 exposure is a known risk factor for acute myocardial infarction (AMI). Myocardial infarction with non-obstructive coronary arteries (MINOCA) represents a distinct subtype of AMI from myocardial infarction with obstructive coronary disease (MI-CAD). Public health measures during the COVID-19 pandemic may have altered exposure patterns, offering a natural experiment. This study investigated changes in the association between short-term exposure to PM2.5 and AMI subtypes following the COVID-19 pandemic. Methods: Using data from the nationwide JROAD-DPC database, this study analysed 270 091 first-admission AMI patients, including 23 037 MINOCA, between April 2012 and March 2022. A time-stratified case-crossover design with conditional logistic regression estimated the odds ratio (OR) for each 10-μg/m³ increase in PM2.5 exposure at a 2-day lag. The study period was divided into pre-pandemic and post-pandemic phases using 7 April 2020, as the threshold. Sensitivity analyses used alternative pandemic onset dates. Results: Each 10-μg/m³ increase in lag-2 PM2.5 was significantly associated with an increased risk of AMI. Although the ORs for overall AMI and MI-CAD remained largely unchanged between periods, a significant attenuation of the PM2.5-related risk for MINOCA was observed (pre-pandemic OR 1.303, 95% confidence interval [CI] 1.005–1.688; post-pandemic OR 1.230, 95% CI: .973–1.555; P for interaction = 0.017). Sensitivity analyses confirmed these findings. Conclusions: Short-term exposure to PM2.5 is associated with increased risk of AMI. The observed reduction in MINOCA risk following the COVID-19 pandemic suggested that public health interventions aimed at reducing air pollution exposure may reduce cardiovascular risks, particularly in specific AMI subtypes.


  • Open Access

    Association Between Physician Experience, Readmission for Heart Failure, and Risk of Mortality in a Super-Aged Society

    by Hiroyuki Mizuta, Masanobu Ishii, Atsushi Tashiro, Yasuhiko Fujita, So Ikebe, Yasuhiro Otsuka, Shinsuke Hanatani, Seiji Takashio, Yasushi Matsuzawa, Eiichiro Yamamoto, et al.

    Background: The increasing prevalence of heart failure (HF) in aging populations challenges healthcare systems, especially in rural and insular regions of super-aged societies. This study examines hospitalization incidence rates (IRs) and the association between physician experience and HF prognosis in an insular super-aged cohort.Methods and Results: We conducted a retrospective population-based observational study including patients first hospitalized for HF between 2015 and 2019. Among 218 patients, 30 in-hospital deaths were excluded and 188 patients were followed up. We estimated hospitalization and readmission IRs and analyzed the association between physician experience and HF prognosis. Additionally, we conducted a landmark analysis 90 days post-discharge for readmissions. The first hospitalization IR for HF was 135/100,000 person-years (112 men, 157 women), and both rates increased with age. The median age was 86 years; 33% were ≥90 years, and 58% were female. Landmark analysis showed that 90-day all-cause mortality was significantly higher in patients with readmission than in those without (P=0.02). The multivariate Cox model confirmed a significant association between 90-day readmissions and all-cause mortality. The physician experience was not significantly associated with HF prognosis.Conclusions: This study highlighted the hospitalization IR for HF in a super-aged society and the high risk of all-cause mortality associated with 90-day readmissions. No significant association was identified between physician experience and HF prognosis.


  • Open Access

    Beyond “lower is better” in antithrombotic strategy for coronary artery disease and atrial fibrillation

    by Masanobu Ishii, Taishi Nakamura, Kenichi Tsujita

  • Open Access

    Predicting Left Ventricular Ejection Fraction Recovery After Percutaneous Coronary Intervention in Patients With Chronic Coronary Syndrome by Using Interpretable Machine Learning Models: Retrospective Study

    by Jiayi Ding, Guanqi Lyu, Masaharu Nakayama, Kotaro Nochioka, Jun Takahashi, Satoshi Yasuda, Tetsuya Matoba, Takahide Kohro, Naoyuki Akashi, Hideo Fujita, et al.

    Background: Accurately predicting left ventricular ejection fraction (LVEF) recovery after percutaneous coronary intervention (PCI) in patients with chronic coronary syndrome (CCS) is crucial for clinical decision-making. Objective: This study aimed to develop and compare multiple machine learning (ML) models to predict LVEF recovery and identify key contributing features. Methods: We retrospectively analyzed 520 patients with CCS from the Clinical Deep Data Accumulation System database. Patients were categorized into 4 binary classification tasks based on baseline LVEF (≥50% or 10% compared with ≤0%; and (2) normal recovery, defined as an LVEF increase of 0% to 10% compared with ≤0%. For each task, 3 feature selection strategies (all features, least absolute shrinkage and selection operator [LASSO] regression, and recursive feature elimination [RFE]) were combined with 4 ML algorithms (extreme gradient boosting [XGBoost], categorical boosting, light gradient boosting machine, and random forest), resulting in 48 models. Models were evaluated using 10-fold cross-validation and assessed by the area under the curve (AUC), decision curve analysis, and calibration plots. Results: The highest AUCs were achieved by RFE combined with XGBoost (AUC=0.93) for preserved LVEF with good recovery, LASSO combined with XGBoost (AUC=0.79) for preserved LVEF with normal recovery, LASSO combined with XGBoost (AUC=0.88) for reduced LVEF with good recovery, and RFE combined with XGBoost (AUC=0.84) for reduced LVEF with normal recovery. Shapley Additive Explanation analysis identified uric acid, platelets, hematocrit, brain natriuretic peptide, glycated hemoglobin, glucose, creatinine, baseline LVEF, left ventricular end-diastolic internal diameter, heart rate, R wave amplitude in V5, and R wave amplitude in V6 as important predictive factors of LVEF recovery. Conclusions: ML models incorporating feature selection strategies demonstrated strong predictive performance for LVEF recovery after PCI. These interpretable models may support clinical decision-making and can improve the management of patients with CCS after PCI.


  • Open Access

    Association between a reduction in triglyceride levels and risk of cardiovascular events

    by Izuki Yamashita, Masanobu Ishii, Tatsuya Tokai, So Ikebe, Yoshinori Yamanouchi, Taishi Nakamura, Kenichi Tsujita

  • Open Access

    Quantifying the contributions of cardiovascular risk factors to cardiovascular disease trends in 21st century Japan: a microsimulation study

    by Soshiro Ogata, Eri Kiyoshige, Yusuke Yoshikawa, Koji Iihara, Hitoshi Fukuda, Masanobu Ishii, Kenichi Tsujita, Anna Head, Brendan Collins, Martin O'FLaherty, et al.


  • Open Access

    Triglycerides and the Risk of Atherosclerotic Cardiovascular Events Across Different Risk Categories

    by Hiroyuki Mizuta, Masanobu Ishii, So Ikebe, Yasuhiro Otsuka, Yoshinori Yamanouchi, Taishi Nakamura, Kenichi Tsujita

    Aims: To investigate the association between triglyceride levels and major adverse cardiovascular events (MACE) in primary and secondary prevention cohorts.Methods: This retrospective study was conducted with a nationwide health insurance claims database, which included approximately 3.8 million participants with medical checkups between January 2005 and August 2020 in Japan. The participants were classified into primary prevention (n=3,415,522) and secondary prevention (n=29,806) cohorts based on cardiovascular or cerebrovascular disease history. Each participant was categorized as having very low (triglyceride <50 mg/dL), low normal (50–99), high normal (100–149), or hypertriglyceridemia (≥ 150). The primary prevention cohort was further stratified into low-, intermediate-, and high-risk groups according to atherosclerotic cardiovascular diseases risk. Outcome was MACE, including acute myocardial infarction (AMI), unstable angina, ischemic stroke, and cardiac death.Results: Over a mean follow-up of 3.25 years, 0.3% and 2.6% MACE occurred in primary and secondary prevention, respectively. Hypertriglyceridemia was associated with high risk of MACE in the primary prevention, but not in the secondary prevention. A significant interaction was observed between prevention categories and the association of TG levels with MACE in those with TG <150 mg/dL and ischemic stroke in those with TG ≥ 150 mg/dL. The population-attributable fraction for hypertriglyceridemia in primary prevention was 4.1% for MACE. In primary prevention, lower risks of AMI were observed in the lower TG category compared to the current threshold.Conclusions: This study suggests distinct triglyceride thresholds for MACE risk in primary and secondary prevention cohorts, requiring further prospective validation for clinical implementation.